Data Bridge Market Research analyses that the Point-of-care Hab1c testing market to account USD 833.06 million by 2028 and growing at a CAGR of 5.59% in the forecast period of 2021-2028.
Request For a Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-hba1c-testing-market
Point-of-care Hab1c testing shows the level of glucose for the period of last 2 to 3 months. It is also called as A1c test. A diabetic patient need to take this test on regular basis to maintain their levels in range.
Surge in the adoption of minimally invasive properties growing number of patients suffering from cardiovascular diseases with lung disorders are the major factors that will influence the growth of Point-of-care Hab1c testing market. Furthermore, growing use of video-assisted surgical systems coupled with the energy based devices and high volume of facilities established for easy use and implementation of cardiac rhythm management devices are the driving factor accelerating the growth of the Point-of-care Hab1c testing market Rising innovations and adoption of advanced technologies for detecting and checking the levels of glucose in patients will further provide beneficial opportunities for the market growth.
However, lack of skilled professionals and complications associated with diabetes such as heart attack stroke kidney failure coma and others will obstruct the market growth. Lack of awareness about these risk and complications will challenge the market of the Point-of-care Hab1c testing.
North America dominates the point-of-care Hab1c testing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major players, high healthcare expenditure and rising use of technological advance devices in hospitals in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing awareness about Hab1c testing changing lifestyle, and increasing population in this region.
The major players covered in the point-of-care Hab1c testing market report are Bio Rad laboratories,Inc. , Arkray INC, A menarini group,F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH , Hemocue Ab, Trinity Biotech , Pts Digonstic, Siemens healthcare gmbh, Alera inc, Danaher, Sugentech,Tech inc, Getein biotech I.N.C, Bio Merieux India Pvt ltd, EKF Diagnostic, other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
